Oblique Therapeutics

Europe Legal Chronicle. February 27, 2023

Oblique Therapeutics’ SEK 53.2 Million Rights Offering

By Federica Tiefenthaler

MAQS advised Oblique Therapeutics on the deal. Oblique Therapeutics AB (publ) completed a rights issue of approximately SEK 53.2 million. Oblique Therapeutics is a privately held...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Edison International’s $550 Million Notes Offering

Derq’s Investment Round

The Middleby Corporation’s Acquisition of JC Ford

‘Mercado Crédito XXVII’ Financial Trusts’ Issuance

Crescera Capital’s Acquisition of Segware

Reddy Ice’s Acquisition of Aguafría

SKB’s Environmental Permit Application for Final Storage of Used Nuclear Fuel

B.P. Marsh & Partners Plc’s Sale Of Lilley Plummer Holdings Ltd.

PLAZZA’s CHF100 Million Bond Placement

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Ora Developers Egypt for Real Estate Investment’s Financing Round

Fourth Milling Company’s Initial Public Offering on Tadawul

A101 Yeni Magazacilik A.S.’ $200 Million Sustainability Loan

ADNH Catering’s US$235 Million Initial Public Offering

Akasa Air’s Partnership with Rolls-Royce for Engine Leasing

OUE Treasury’s Green Bond Offering

Sembcorp Industries’ Notes Issuance

Senior M&A Lawyer Deepa Vallabh Joins Bowmans in Johannesburg

Michael R. Guerrero Returns to Hinshaw’s Consumer Financial Services Group in California

James Barbaria Joins Hinshaw & Culbertson LLP as Chief Financial Officer

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Senior M&A Lawyer Deepa Vallabh Joins Bowmans in Johannesburg

Michael R. Guerrero Returns to Hinshaw’s Consumer Financial Services Group in California

James Barbaria Joins Hinshaw & Culbertson LLP as Chief Financial Officer

Oblique Therapeutics’ SEK 53.2 Million Rights Offering

Standard 1 Year Membership Required